ABSTRACT
Background: There is a growing need to understand the risk factors and prevalence of AKI in COVID-19 patients to better manage and prevent the condition. HIMS, Hassan is a hospital in India that has been treating COVID-19 patients since the onset of the pandemic. This study aimed to determine the prevalence of acute kidney injury (AKI) in COVID-19 patients admitted to a hospital in HIMS, Hassan, and to identify the associated risk factors. Methods: The study is a retrospective cohort study that investigates the clinical characteristics and laboratory parameters of hospitalized COVID-19 patients who met the inclusion criteria in HIMS teaching hospital, Hassan. 300 patients were included, and descriptive statistical analysis was performed using mean with standard deviation (SD) for continuous variables and proportions and percentages for categorical variables. Results: Out of 300 patients, 68% had AKI. The age distribution was similar between the two groups, with the highest proportion of patients in the age group of 40-49 years. The proportion of AKI was higher among males than females, but the difference was not statistically significant. The need for ICU admission, mechanical ventilation, and dialysis was strongly associated with AKI. Patients with comorbidities such as DM and DM+HTN were at a higher risk of developing AKI. Laboratory parameters such as D-dimer, LDH, ferritin, urea, creatinine, SGOT, SGPT, Neutrophils / Lymphocytes ratio, and chloride levels were significantly different between the two groups. Conclusions: These findings highlight the importance of monitoring patients with comorbidities closely and implementing preventive measures to reduce the incidence of AKI in COVID-19 patients.
ABSTRACT
Background: There is a growing need to understand the risk factors and prevalence of AKI in COVID-19 patients to better manage and prevent the condition. HIMS, Hassan is a hospital in India that has been treating COVID-19 patients since the onset of the pandemic. This study aimed to determine the prevalence of acute kidney injury (AKI) in COVID-19 patients admitted to a hospital in HIMS, Hassan, and to identify the associated risk factors. Methods: The study is a retrospective cohort study that investigates the clinical characteristics and laboratory parameters of hospitalized COVID-19 patients who met the inclusion criteria in HIMS teaching hospital, Hassan. 300 patients were included, and descriptive statistical analysis was performed using mean with standard deviation (SD) for continuous variables and proportions and percentages for categorical variables. Results: Out of 300 patients, 68% had AKI. The age distribution was similar between the two groups, with the highest proportion of patients in the age group of 40-49 years. The proportion of AKI was higher among males than females, but the difference was not statistically significant. The need for ICU admission, mechanical ventilation, and dialysis was strongly associated with AKI. Patients with comorbidities such as DM and DM+HTN were at a higher risk of developing AKI. Laboratory parameters such as D-dimer, LDH, ferritin, urea, creatinine, SGOT, SGPT, Neutrophils / Lymphocytes ratio, and chloride levels were significantly different between the two groups. Conclusions: These findings highlight the importance of monitoring patients with comorbidities closely and implementing preventive measures to reduce the incidence of AKI in COVID-19 patients.
ABSTRACT
One of the major etiologies of lipid disorders in malignancies is the use of chemotherapy drugs, the most important of which is L-Asparginase. Studies in different centers with high dosages of L-Asparginase demonstrated different results. The aim of this study is to evaluate the effect of L-Asparginase at a dose of 6000 U/m2 on lipid profile in Iranian children with newly diagnosed acute lymphoblastic leukemia in Mofid Children Hospital of Tehran. We performed a nonrandomized trial in which all children with newly diagnosed acute lymphoblastic leukemia [ALL] aged <15 years participated. Every case serves as his/her own control. The cholesterol, triglyceride [TG], HDL, LDL, VLDL, APOA, APOB and LPa were evaluated in three stages: before, during and 2 months after treatment with L-Asparginase after which the results were compared. In our study, 82 newly ALL diagnosed patients with the mean age of 6 years [within the age range of 0.12-14 and SD of 3.5] were evaluated. Mean seum level of TG in pretreatment stage was 163.9 mg% and during treatment with L-Asparginase 123 mg% demonstrating significant decline in TG serum level after administration of L-Asparginase [p=0.002]. Mean serum level of cholesterol before administration of L-Asparginase was 151mg% and during treatment 140 showing no statistically significant difference [p= 0.061]. LPa level in pretreatment phase was 24mg% and during treatment 14 showing a statistically significant difference [p= 0.0001]. L-Aspar resulted in decline in TG serum level and increase in HDL though with no significant difference in cholesterol level. Overall, L-Asparginase even at a dose of 6000U/M2 does not raise blood level of triglyceride and cholesterol